Cargando…
Impact of Central Nervous System International Prognostic Index on the Treatment of Diffuse Large B Cell Lymphoma
Background The central nervous system international prognostic index (CNS-IPI) is being used widely for the identification of patients with diffuse large B cell lymphoma (DLBCL) with a high risk of central nervous system (CNS) relapse. The aim of our study is to confirm the value of the CNS-IPI in p...
Autores principales: | Ma'koseh, Mohammad, Tamimi, Faris, Abufara, Alaa, Abusalem, Lana, Salama, Osama, Saleh, Yacob, Khader, Rnad, Faiyoumi, Baha A, Al-Rwashdeh, Mohammad, Halahleh, Khaled |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407468/ https://www.ncbi.nlm.nih.gov/pubmed/34513408 http://dx.doi.org/10.7759/cureus.16802 |
Ejemplares similares
-
Treatment of adult Burkitt lymphoma with the CALGB 1002 protocol: a single center experience in Jordan
por: Ma’koseh, Mohammad, et al.
Publicado: (2021) -
The Application of the Lymphoma International Prognostic Index to Predict Venous Thromboembolic Events in Diffuse Large B-Cell Lymphoma Patients
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2021) -
The Application of the ThroLy Risk Assessment Model to Predict Venous
Thromboembolism in Patients with Diffuse Large B-Cell Lymphoma
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2021) -
Outcome of Primary Mediastinal Large B Cell Lymphoma Treated with RCHOP
por: Halahleh, Khalid, et al.
Publicado: (2023) -
Classical Hodgkin Lymphoma on the Background of Castleman Disease: A Case Report
por: Ma'koseh, Mohammad, et al.
Publicado: (2023)